Work

ACTION3 Phase 3 Clinical Trial Assessing the Efficacy and Safety of DMX-200 (Repagermanium): Mid-trial Safety Assessment and Pharmacometric Model-Informed Pediatric Dose Selection

Year: 2024

Type: article

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.2024qfbcfxw7

Authors: David E. Fuller, Erno van Schaick, Alisha J. Smith, Robert Shepherd, Carl White

Language: English

Topic: Pharmaceutical studies and practices

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403834388

FWCI:

Cites:

Cited by:

Related to: 10